Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib + Abiraterone (PROceed)

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

February 14, 2024

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
Metastatic Castration-resistant Prostate Cancer
Trial Locations (34)

Unknown

RECRUITING

Research Site, Aschaffenburg

RECRUITING

Research Site, Augsburg

RECRUITING

Research Site, Bergisch Gladbach

RECRUITING

Research Site, Berlin

RECRUITING

Research Site, Bonn

RECRUITING

Research Site, Cologne

RECRUITING

Research Site, Dresden

RECRUITING

Research Site, Duisburg

RECRUITING

Research Site, Eisenach

RECRUITING

Research Site, Eisleben Lutherstadt

RECRUITING

Research Site, Frankfurt

RECRUITING

Research Site, Greifswald

RECRUITING

Research Site, Halle

RECRUITING

Research Site, Hamburg

RECRUITING

Research Site, Hanover

RECRUITING

Research Site, Heidelberg

RECRUITING

Research Site, Heinsberg

RECRUITING

Research Site, Herzogenaurach

RECRUITING

Research Site, Leipzig

RECRUITING

Research Site, Lübeck

RECRUITING

Research Site, Lüneburg

RECRUITING

Research Site, Magdeburg

RECRUITING

Research Site, Marburg

RECRUITING

Research Site, Mülheim

RECRUITING

Research Site, Münster

RECRUITING

Research Site, Neunkirchen

RECRUITING

Research Site, Nuremberg

RECRUITING

Research Site, Rüsselsheim am Main

RECRUITING

Research Site, Saalfeld

RECRUITING

Research Site, Speyer

RECRUITING

Research Site, Trier

RECRUITING

Research Site, Tübingen

RECRUITING

Research Site, Westerstede

RECRUITING

Research Site, Wetzlar

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

AstraZeneca

INDUSTRY